Hospital Acquired/Ventilator Associated Pneumonia Clinical Trial

One of the core PSI clinical trial strengths is predictable  patient enrollment across numerous therapeutic areas. This includes a variety of infectious disease indications, one of which is HAP/VAP pneumonia.

Infectious disease clinical trials are one of the therapeutic areas in which PSI project management philosophy has proven effective time after time. The PSI clinical team effectively manage site relationships, support PSI investigators and meet enrollment goals. 

Recognizing the challenges in these type of  clinical trials, PSI selects  highly-experienced professional investigators who can  pool a sufficient number of patients from the target populatioon in advance. The Actual vs. Planned enrollment graphs below presents PSI’s continued on-time enrollment performance.

Please contact us for more information on PSI’s clinical trial experience in this therapeutic area.